Daniel Sundheim’s Medline Inc MDLN Stock Holding History

Daniel Sundheim’s Portfolio MDLN Stock Details MDLN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	–	Sell	-377,131	Closed	-$15.8M	–	58
2025 Q4	$15.8M	Buy	+377,131	New	+$15.9M	0.15%	42

Other funds holding MDLN

Carlyle Group Washington, District of Columbia $10B AUM 10.61% 1-Year Est. Return

HFCIX

H&F Corporate Investors X San Francisco, California $2.8B AUM

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return

Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

LPC

Lone Pine Capital Greenwich, Connecticut $16.4B AUM 99.7% 1-Year Est. Return

Daniel Sundheim's MDLN Position: Q1 2026 in Review

Daniel Sundheim sold out of Medline Inc (MDLN) in Q1 2026, closing a stake of 377,131 shares — an estimated $15.8M sold.

Daniel Sundheim first reported a position in MDLN in Q4 2025 and held it in 1 quarter. The position peaked at $15.8M in Q4 2025. 314 funds tracked by Wall St. Rank hold MDLN as of Q1 2026.

Daniel Sundheim reported no remaining Medline Inc position as of Q1 2026 after selling out during the quarter.
Daniel Sundheim sold 377,131 Medline Inc shares in Q1 2026, an estimated $15.8M.
Daniel Sundheim first reported a position in Medline Inc in Q4 2025 and held it in 1 quarter.
Daniel Sundheim's Medline Inc position peaked at $15.8M in Q4 2025.
314 funds tracked by Wall St. Rank held Medline Inc as of Q1 2026.

Based on D1 Capital Partners's 13F filing for Q1 2026, filed 15 May 2026.